Found: 2
Select item for more details and to access through your institution.
Histone deacetylase (HDAC) inhibitors and doxorubicin combinations target both breast cancer stem cells and non-stem breast cancer cells simultaneously.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 179, n. 3, p. 615, doi. 10.1007/s10549-019-05504-5
- By:
- Publication type:
- Article
Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation.
- Published in:
- 2016
- By:
- Publication type:
- journal article